China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025

SHENZHEN, CHINA, Feb 14, 2025 – (ACN Newswire) – In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited (“CMS” or the “Group”) has been included in the S&P Global Sustainability Yearbook 2025 (the “Yearbook 2025”). This marks the Group’s first inclusion…

S Experience and Kingsmen Xperience Announce a Strategic Partnership Deal Memorandum

HONG KONG, Feb 13, 2025 - (ACN Newswire via SeaPRwire.com) - Black Spade Capital Limited (“Black Spade”) announced today that its subsidiary S Experience Limited (“S Experience”) has entered into a strategic deal memorandum with Kingsmen Xperience, Inc. (“Kingsmen Xperience”), the United States location-based entertainment-focused subsidiary of Kingsmen Creatives Ltd.…

Giftify Deploys Enterprise AI Solutions Driving Operational Excellence and Innovation

Schaumburg, Illinois, Feb 13, 2025 - (ACN Newswire via SeaPRwire.com) - Giftify, Inc. (NASDAQ: GIFT) (the “Company”), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced the successful enterprise-wide deployment of artificial intelligence (AI) solutions. Initial results from this deployment…

JioCinema and Virtual 5G Express Plus Partner for Global OTT Access; Marketing Campaign Launched “`

SINGAPORE, Feb. 13, 2025 — Virtual Internet launched a joint solution featuring JioCinema and Virtual 5G Express Plus. This marketing campaign, targeting JioCinema users, highlights the global accessibility of services enabled by Virtual 5G Express Plus. The campaign will utilize a multi-platform approach, encompassing both social and traditional media.    …

SoftBank Reports Q3 Losses Amid Market Volatility “`

SoftBank Group's third-quarter results surprised investors with a substantial net loss, a consequence of volatile market conditions impacting its investment strategy. This outcome contradicts analysts' predictions of a profitable quarter, highlighting the difficulties SoftBank faces navigating current global economic challenges affecting its significant investments. The Vision Fund, renowned for significant…

DAAN Biotherapeutics and LigaChem Biosciences Partner on Exclusive Antibody Licensing for ADC Development

SEOUL, South Korea, Feb. 13, 2025 — DAAN Biotherapeutics, a leading innovator in TCR-based therapies, has granted LigaChem Biosciences exclusive rights to a novel, tumor-targeting antibody. This agreement will advance the development and market launch of Antibody-Drug Conjugates (ADCs). This collaboration allows LigaChem Biosciences to significantly progress its ADC development…